Skip to main content
Premium Trial:

Request an Annual Quote

Gene Logic Licenses Parts of GeneExpress to Morphochem

NEW YORK, Feb. 19 - Gene Logic on Tuesday said that Morphochem has subscribed to parts of its GeneExpress technology.

Morphochem researchers will use the GeneExpress oncology DataSuite and the  Reports tool, which was designed to offer a body-wide assessment of targeted genes. 

Terms of the non-exclusive, multiyear agreement also call for Gene Logic to generate data from samples provided by Morphochem and then provide these additional data to Morphochem.

Financial details of deal were not disclosed.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.